Cervical Smear (CervicalCheck) Misread Claims

Understanding CervicalCheck and Screening in Ireland

To understand how errors can occur, it is important to first understand the system itself. The National Cervical Screening Programme, known as CervicalCheck, is not a diagnostic service. Its primary purpose is not to diagnose cancer, but to reduce the risk of cervical cancer developing in the population.

A screening test looks for early warning signs in healthy people who do not have symptoms. It is a risk reduction tool. While the programme saves many lives every year by detecting changes early, no screening test is 100% perfect. However, while limitations exist, there is a distinct difference between the natural limitations of a test and a failure to adhere to an acceptable standard of reporting.

What a “smear test” result actually represents

It is a common misconception that a clear smear test is a guarantee that you are cancer-free. Instead, a smear test acts as a risk assessment. It takes a sample of cells from the cervix to check for high-risk Human Papillomavirus (HPV) or abnormal cell changes.

If a test is reported as normal, it means the risk is considered low enough that you do not need to be seen until your next scheduled recall. However, accuracy is essential. Patients rely on these results to make decisions about their health. If a screener fails to spot abnormalities that were clearly visible on the slide, the result provided to you does not accurately reflect your risk, potentially delaying vital treatment.

Terms often seen in result letters

When reviewing your history or medical files, you may encounter specific medical terminology. Understanding these terms is the first step in making sense of your screening record:

• HPV Positive/Negative: Most screening now tests for the Human Papillomavirus first. HPV Positive means the virus is present, requiring the sample to be checked for cell changes. HPV Negative generally means your risk is low, and your next test will be in 3 to 5 years.
• Cytology: This simply refers to the examination of cells under a microscope. If you are HPV positive, a cytologist looks at your sample to see if the virus has damaged the cells.
• Dyskaryosis: This is the medical term for abnormal cell changes on the cervix. It is not cancer, but it can be a pre-cancerous warning sign. It is usually graded as low-grade (mild) or high-grade (moderate to severe).
• Inadequate Sample: This means the laboratory could not read your sample properly, perhaps because there were not enough cells collected or there was blood obscuring the view. It is not a result; it is a request for a repeat test.
• CIN (Cervical Intraepithelial Neoplasia): This classification is usually used after a biopsy (colposcopy) rather than the smear itself, grading the depth of abnormal changes on the surface of the cervix (e.g., CIN 1, CIN 2, or CIN 3).

What “Misread” Means in a Cervical Smear Context

In the laboratory, highly trained scientists (cytoscreeners) and consultant pathologists review thousands of slides. It is a visual process that relies on human interpretation. While a certain margin of error is statistically expected in any screening programme, a "misread" in a legal context refers to a specific failure. It means that abnormalities were present on the slide and should have been identified by a competent screener, but were missed or interpreted incorrectly.

False-negative results (missed abnormalities)

A false-negative result is the most common basis for a claim in this area. This occurs when a patient receives a "normal" or "no abnormalities detected" result, despite the fact that evidence of pre-cancerous or cancerous cells was visible on the slide at the time.

If an independent review later confirms that a competent screener acting with ordinary care would have spotted these cells, the original negative result may be considered negligent. This error gives the patient false reassurance, leading to a delay in referral for further investigation, such as a colposcopy.

False-positive results (incorrectly reported abnormalities)

Conversely, a false-positive result occurs when a woman is told she has abnormalities when, in fact, her cells are healthy. While less common in high-profile litigation, the impact is significant. It can lead to unnecessary invasive procedures, such as biopsies or LLETZ treatments (removal of tissue), which carry their own risks and side effects. It also causes profound psychological distress and anxiety for the patient and her family.

Interval cancers vs. screening errors

One of the most critical distinctions to make in these cases is between a "screening error" and an "interval cancer." Not every woman who develops cancer after a normal smear has been a victim of negligence.

• Screening Error: The cancer or pre-cancer was present on the previous slide but was missed by the laboratory.
• Interval Cancer: The previous slide was genuinely normal, but a new cancer developed rapidly in the time between the screening appointments.

Distinguishing between these two scenarios requires a forensic retrospective review of the original slides. If the cancer developed rapidly (interval cancer), the laboratory is not at fault. However, if the signs were there and missed, there may be a case to answer.

Administrative and reporting errors

Sometimes, the error is not in the microscope, but in the paperwork. The CervicalCheck system relies on complex logistics to link women, GPs, and laboratories. Failures here can include:

• Labelling errors: Where a sample is assigned to the wrong patient file.
• Patient matching errors: Where results are sent to an old address or a GP the patient no longer attends.
• Communication failures: Where a result requiring urgent action is issued by the lab but never communicated to the patient or their doctor, leading to a drift in care.

How Smear Test Errors Can Occur

The path from a GP surgery to a laboratory result involves multiple steps. Errors can be systemic (process-based) or individual (human error). Identifying exactly where the breakdown occurred is a central part of investigating a claim.

Laboratory and human factors

Laboratories process a massive volume of slides. To manage this, strict quality control protocols must be in place. Errors can happen due to:

• Volume and fatigue: Screeners working under immense pressure or reviewing too many slides in a single shift may suffer from concentration lapses.
• Interpretation thresholds: Sometimes, cells are "borderline." A screener might classify them as normal inflammation, while another might flag them as suspicious. If the laboratory's threshold for flagging cells is set too high, abnormalities may be dismissed.
• Quality control failures: A percentage of "normal" slides are supposed to be re-checked by a second screener. If this safety net fails or is not robust enough, errors can slip through.

Sample collection issues

A result is only as good as the sample provided. If the person taking the smear (usually a GP or practice nurse) does not collect cells from the transformation zone,the specific area of the cervix where cell changes most commonly occur,the laboratory may not have the right material to analyse.

If a sample is "inadequate," the lab should reject it and ask for a repeat. However, if an inadequate sample is processed and reported as "normal" despite the lack of relevant cells, the patient is left with a dangerous gap in her screening history.

Failures in follow-up care

A correct result is useless if it is not acted upon. There are strict protocols dictating what must happen after an abnormal result. Negligence can occur if:

• A recommendation for a repeat test in 6 months is ignored.
• A referral to a colposcopy clinic (for a closer look) is not sent.
• The patient is not informed of the need for follow-up, assuming "no news is good news."

Missed opportunities when symptoms were present

The CervicalCheck programme is for asymptomatic women. If a woman goes to her GP complaining of symptoms such as irregular bleeding, pelvic pain, or discharge, she requires diagnostic investigation, not just a screening test.

A common failure occurs when a patient presents with symptoms, but the medical provider relies solely on a previous "normal" smear result to rule out cancer. This is clinically dangerous. A smear test can be false-negative; therefore, symptoms must always be investigated on their own merits, regardless of screening history.

The CervicalCheck Audits and Disclosure Process

Following the diagnosis of cervical cancer, the CervicalCheck programme routinely conducted audits (reviews) of previous screening tests for educational and quality assurance purposes. In many cases, these audits revealed that earlier slides,originally marked as normal,actually contained abnormalities.

The controversy arose because this information was not shared with the women affected. While the audit itself is a quality control measure, the failure to disclose the findings denied women the truth about their medical history. Today, patients are far more aware of the necessity of checking their audit history.

The "Personal Cervical Screening Review"

If you have been diagnosed with cervical cancer, you have a right to request a Personal Cervical Screening Review from the HSE. This is a process where the HSE looks back at your screening history to see if the correct procedures were followed.

While this is a helpful first step, it is an internal HSE process. For a legal investigation, an independent review is usually required to ensure impartiality. You can read more about the HSE's review process on their official website.

Practical Steps if You Are Concerned About a Misread Smear

If you are worried about your screening history or a recent diagnosis, it can be difficult to know where to turn. Taking methodical steps can help you regain a sense of control.

Immediate health considerations

Your health is the priority. If you have received a diagnosis of cancer, your focus must be on your treatment plan. However, if you are currently healthy but have concerns about administrative errors or symptoms:

• Consult your GP immediately if you have any symptoms like irregular bleeding, regardless of your last smear result.
• Contact CervicalCheck to ensure your address and details are correct if you feel you have missed a letter.

Building a timeline of your care

To assist a solicitor or medical expert in reviewing your case, try to construct a timeline of your history. This does not need to be perfect, but it helps to establish a sequence of events. Try to recall:

• The approximate dates of your smear tests over the last 10 years.
• When you received result letters and what they said.
• Any dates you visited your GP with specific gynaecological complaints.
• The date of your cancer diagnosis.

Documents that are helpful to keep

Documentation is evidence. While your legal team will eventually request your full file directly from the healthcare providers, it is helpful to gather what you have at home:

• Result letters from CervicalCheck.
• Referral letters to hospitals or colposcopy clinics.
• Discharge summaries or letters from your oncologist.
• Any correspondence regarding a "Clinical Audit" or "Patient Review."

Steps for families of deceased patients

Tragically, some women pass away before the errors in their care are discovered. If you are the husband, partner, or child of a woman who died from cervical cancer, you have the right to investigate her care on behalf of her estate and dependents. This is a deeply emotional process, but it can provide answers and financial security for the family left behind. The process for requesting records remains the same, though you will need to show you are the legal representative (e.g., executor) of the estate.

Legal Routes: The Tribunal and the Courts

In Ireland, there are currently two primary routes for seeking redress regarding cervical screening errors. Choosing the right path depends on your specific circumstances and preferences.

The CervicalCheck Tribunal

The CervicalCheck Tribunal was established by statute to provide an alternative to the court system for women affected by the specific issues identified in the 2018 audits. It is designed to be less adversarial and faster than the High Court. The Tribunal hears claims and makes awards for damages. It is important to note that if you choose to go through the Tribunal, you generally cannot then take the same case to court.

The Court process for clinical negligence

The traditional route is pursuing a High Court action for medical negligence. This involves issuing proceedings against the HSE and/or the specific laboratories involved. While this route can take longer, it allows for a rigorous examination of the evidence. For many complex cases, or cases falling outside the specific scope of the Tribunal, the High Court remains the appropriate venue to ensure full justice is achieved.

Proving the case: Duty, breach, and causation

To succeed in a legal claim, three elements must be proven. We explain these in plain English:

1. Duty of Care: It must be shown that the laboratory or doctor owed you a duty of care (this is automatic in a patient-doctor relationship).
2. Breach of Duty: It must be proven that the care provided fell below an acceptable standard. For a smear test, this means proving that a competent screener would not have missed the abnormality that was on the slide. This is often called the "standard of care."
3. Causation: This is often the most complex part. It must be proven that the breach (the missed smear) actually caused the injury. We must show that if the cancer had been caught earlier, the outcome would have been different,for example, a simple procedure instead of chemotherapy, or a cure instead of a terminal diagnosis.

Time Limits and the “Date of Knowledge” in Ireland

In Ireland, the Statute of Limitations generally allows two years to bring a claim for medical negligence. Usually, this clock starts ticking from the date the injury occurred. However, with misread smears, the error might have happened years before you found out about it.

This is where the "Date of Knowledge" becomes critical. In many cervical cancer cases, the two-year limit does not start from the date of the misread test, but from the date you first knew (or should have known) that an error had occurred. For many women, this is the date they were informed of an audit result, or the date an independent expert confirmed the negligence.

Exceptions to the standard time limits

There are important exceptions to these strict time limits:

• Fatal Injury Actions: Families usually have two years from the date of death to bring a claim.
• Those lacking capacity: If a person cannot manage their own affairs due to illness or injury, the time limits may be paused.
• Discretion: In rare circumstances, the Courts have the discretion to extend time, but this should never be relied upon.

Important: Determining your specific "date of knowledge" is a legal question. Do not assume you are "out of time" without speaking to a solicitor.

What an Investigation Into a Misread Smear Involves

Investigating these claims is a forensic and detailed process. It is not simply a matter of filing a complaint; it involves gathering scientific evidence. When we investigate a claim, the process generally follows this structure:

• Obtaining the full screening history file: We request the complete administrative and medical file from CervicalCheck and the HSE.
• Securing the physical slides: We manage the complex logistics of retrieving the original glass slides from the laboratories (which may be in Ireland or the US).
• Independent expert analysis: We instruct leading consultant cytopathologists and gynaecologists to review the slides blindly. They determine if negligence occurred.
• Reviewing the impact on prognosis: If negligence is found, an oncologist helps us understand how the delay affected your life expectancy and treatment needs.

FAQs

Can I request a review if I developed cancer after a normal smear?

Yes. If you have been diagnosed with cervical cancer after receiving a normal screening result, you are entitled to have your previous screening history reviewed to see if an error occurred.

Does a misread smear always mean negligence occurred?

No. Screening has limitations, and sometimes cells are difficult to interpret. Negligence is only proven if an independent expert confirms that the abnormalities were clear enough that no competent screener should have missed them.

What is the difference between an audit and a personal review?

An audit is often a routine quality check done by the screening programme (sometimes without the patient's knowledge). A personal review is a specific investigation initiated by you or the HSE after a diagnosis to check your history.

Can a family member investigate a claim if the patient has passed away?

Yes. The family of a deceased patient can pursue a claim for "Fatal Injury." This investigates whether the misread smear contributed to the death and seeks security for the dependents left behind.

Do I have to go to the Tribunal or can I go to Court?

You typically have a choice, provided you meet the criteria for the Tribunal. However, you generally cannot do both. A solicitor can advise you on which route is best for your specific circumstances.

What if my smear tests were sent to a laboratory in the US?

Many Irish smear tests were processed in US laboratories. This does not prevent you from bringing a claim in Ireland. The legal process can still address errors made by these outsourced laboratories.

How much does it cost to investigate a claim?

This varies. At Michael Boylan LLP, we discuss all costs transparently at the outset. In many cases, we can investigate the initial merits of the case before significant costs are incurred.

Will I have to go to court and give evidence?

Most medical negligence cases settle before reaching a full trial. While we prepare every case as if it will go to court to ensure the best outcome, the vast majority are resolved through negotiation or mediation.

How Michael Boylan LLP Can Assist

At Michael Boylan LLP, we are recognised as one of Ireland’s leading medical negligence firms. We have extensive experience in handling complex cancer misdiagnosis claims, including high-profile CervicalCheck cases. We know that behind every file is a woman, a family, and a life turned upside down.

Initial, confidential discussions

We offer an initial consultation to listen to your story. This is a safe, confidential space where you can ask questions without any pressure to proceed. We will give you an honest assessment of whether we believe there are grounds for an investigation.

Managing the investigation process

The process of retrieving slides, instructing international experts, and interpreting medical reports is complex and burdensome. We handle this entire process for you. Our goal is to lift the legal and administrative weight off your shoulders so you can focus on your health and your family.

Privacy and sensitivity

We understand the deeply personal and invasive nature of gynaecological claims. Our team approaches every case with the utmost sensitivity, discretion, and respect for your dignity. You will be treated with compassion and professionalism at every step.

Secure Your Future and Your Family’s Peace of Mind

If you have concerns about your cervical screening history or have suffered due to a delayed diagnosis, do not face the uncertainty alone. Time limits apply, so it is vital to seek advice as soon as you are able.

Contact Michael Boylan LLP today for a confidential, no-obligation discussion about your legal options.

*In contentious business, a solicitor may not calculate fees or other charges as a percentage or proportion of any award or settlement.